Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer

被引:34
|
作者
Pastille, Eva [1 ]
Fassnacht, Tabea [1 ]
Adamczyk, Alexandra [1 ]
Nhi Ngo Thi Phuong [1 ]
Buer, Jan [1 ]
Westendorf, Astrid M. [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
关键词
Toll-like receptor 4; colitis-associated colon cancer; inflammation; TAK-242; intestinal immune cells; COLORECTAL-CANCER; GUT MICROBIOTA; TOLL; RECEPTOR-4; RISK;
D O I
10.3389/fimmu.2021.669747
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients suffering from ulcerative colitis are at increased risk of developing colorectal cancer. Although the exact underlying mechanisms of inflammation-associated carcinogenesis remain unknown, the intestinal microbiota as well as pathogenic bacteria are discussed as contributors to inflammation and colitis-associated colon cancer (CAC). In the present study, we analyzed the impact of TLR4, the receptor for Gram-negative bacteria derived lipopolysaccharides, on intestinal inflammation and tumorigenesis in a murine model of CAC. During the inflammatory phases of CAC development, we observed a strong upregulation of Tlr4 expression in colonic tissues. Blocking of TLR4 signaling by a small-molecule-specific inhibitor during the inflammatory phases of CAC strongly diminished the development and progression of colonic tumors, which was accompanied by decreased numbers of infiltrating macrophages and reduced colonic pro-inflammatory cytokine levels compared to CAC control mice. Interestingly, inhibiting bacterial signaling by antibiotic treatment during the inflammatory phases of CAC also protected mice from severe intestinal inflammation and almost completely prevented tumor growth. Nevertheless, application of antibiotics involved rapid and severe body weight loss and might have unwanted side effects. Our results indicate that bacterial activation of TLR4 on innate immune cells in the colon triggers inflammation and promotes tumor growth. Thus, the inhibition of the TLR4 signaling during intestinal inflammation might be a novel approach to impede CAC development.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer
    Marjaneh, Reyhaneh Moradi
    Rahmani, Farzad
    Hassanian, Seyed Mahdi
    Rezaei, Nastaran
    Hashemzehi, Milad
    Bahrami, Afsane
    Ariakia, Fatemeh
    Fiuji, Hamid
    Sahebkar, Amirhosein
    Avan, Amir
    Khazaei, Majid
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (10) : 6785 - 6798
  • [32] Phosphatidylinositol 3-Kinase γ Inhibition Ameliorates Inflammation and Tumor Growth in a Model of Colitis-Associated Cancer
    Gonzalez-Garcia, Ana
    Sanchez-Ruiz, Jesus
    Flores, Juana M.
    Carrera, Ana C.
    GASTROENTEROLOGY, 2010, 138 (04) : 1374 - 1383
  • [33] A Toll-Like Receptor 4 (TLR4) Antibody Antagonist Can Prevent Colitis-Associated Neoplasia
    Fukata, Masayuki
    Espana, Cecilia
    Ungaro, Ryan
    Sotolongo, John P.
    Pastorini, Cristhine
    Altman, Norman
    Zaias, Julia
    Vamadevan, Arunan S.
    Santaolalla, Rebeca
    Elson, Greg
    Kosco-Vilbois, Marie
    Hayes, Lory
    Abreu, Maria T.
    GASTROENTEROLOGY, 2010, 138 (05) : S445 - S445
  • [34] Potential of Glycyrrhiza in the prevention of colitis-associated colon cancer
    Liu, Fang
    Gu, Zhili
    Yi, Feiyang
    Liu, Xue
    Zou, Wenxuan
    Xu, Qingxia
    Yuan, Yun
    Chen, Nianzhi
    Tang, Jianyuan
    FITOTERAPIA, 2025, 181
  • [35] Thrombin Drives Tumorigenesis in Colitis-Associated Colon Cancer
    Turpin, Brian
    Miller, Whitney
    Rosenfeldt, Leah
    Kombrinck, Keith
    Flick, Matthew J.
    Steinbrecher, Kris A.
    Harmel-Laws, Eleana
    Mullins, Eric S.
    Shaw, Maureen
    Witte, David P.
    Revenko, Alexey
    Monia, Brett
    Palumbo, Joseph S.
    CANCER RESEARCH, 2014, 74 (11) : 3020 - 3030
  • [36] SPP1 in colitis-associated colon cancer
    Manna, S.
    da Silva, D. Cardoso
    Sehn, M.
    Wiese, J.
    Heldt, C.
    Plumbom, I.
    Conrad, T.
    Schallenberg, S.
    Dony, V.
    Farahani, S. K.
    Weiss, F.
    Branchi, F.
    Elezkurtaj, S.
    Siegmund, B.
    Weixler, B.
    Hummel, M.
    Groene, J.
    Schumann, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I42 - I43
  • [37] SPP1 in colitis-associated colon cancer
    Manna, S.
    Sehn, M.
    da Silva, D. Cardoso
    Liu, X.
    Wiese, J. J.
    Heldt, C.
    Siegmund, B.
    Hummel, M.
    Schumann, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i139 - i140
  • [38] Relative Role of Methylator and Tumor Suppressor Pathways in Ulcerative Colitis-associated Colon Cancer
    Sanchez, Julian A.
    DeJulius, Kathryn L.
    Bronner, Mary
    Church, James M.
    Kalady, Matthew F.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (09) : 1966 - 1970
  • [39] Interleukin 23 and Tumor-Elicited Inflammation in Colitis-Associated and Spontaneous Colon Cancer
    Grivennikov, Sergei
    Wang, Kepeng
    Karin, Michael
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S95 - S95
  • [40] Swimming Impedes Intestinal Microbiota and Lipid Metabolites of Tumorigenesis in Colitis-Associated Cancer
    Wang, Weiyi
    Xu, Ying
    Wang, Xiaofeng
    Chu, Yimin
    Zhang, Haiqin
    Zhou, Lu
    Zhu, Haijin
    Li, Ji
    Kuai, Rong
    Zhou, Fengli
    Yang, Daming
    Peng, Haixia
    FRONTIERS IN ONCOLOGY, 2022, 12